3778-26-5

Basic information

• Product Name: 8-[5-(5,7-dimethoxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl]-5,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one
• CAS NO: 3778-26-5
• Molecular Formula: C₃₆H₃₀O₁₀
• Molecular Weight: 622.6174
• Mol File: 3778-26-5.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 810.1°C at 760 mmHg
• Flash Point: 243°C
• Density: 1.301g/cm³
• Vapor Pressure: 2.67E-26mmHg at 25°C
• Refractive Index: 1.614
• CAS DataBase Reference: 8-[5-(5,7-dimethoxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl]-5,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 8-[5-(5,7-dimethoxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl]-5,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one(3778-26-5)
• EPA Substance Registry System: 8-[5-(5,7-dimethoxy-4-oxo-4H-chromen-2-yl)-2-methoxyphenyl]-5,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one(3778-26-5)

Safety Data

• Hazardous Substances Data: 3778-26-5(Hazardous Substances Data)

Upstream product

• 548-19-6 isoginkgetin 
• 74-88-4 methyl iodide 
• 135159-05-6 5,7-Dimethoxy-2-(6,2',4',6'-tetramethoxy-biphenyl-3-yl)-chromen-4-one 
• 135159-25-0 (2,4,6-trimethoxyphenyl)boronic acid 
• 3754-52-7 3'-iodo-5,7,4'-trimethoxyflavone 
• 77-78-1 dimethyl sulfate 
• 21763-71-3 Sequoiaflavone 
• 135159-06-7 2-{2'-Hydroxy-6,4',6'-trimethoxy-3'-[(E)-3-(4-methoxy-phenyl)-acryloyl]-biphenyl-3-yl}-5,7-dimethoxy-chromen-4-one 
• 1617-53-4 amentoflavone 
• 1165-94-2 8-iodo-5,7-dimethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one 

Downstream Products

• 90-24-4 2-hydroxy-4,6-dimethoxyacetophenone 
• 3187-19-7 2,4-dimethoxysalicylic acid 
• 3778-25-4 7,4',7'',4'''-tetra-O-methylamentoflavone 
• 107225-53-6 8-[5-(5,7-dimethoxy-4-hydroxyimino-4H-chromen-2-yl)-2-methoxy-phenyl]-5,7-dimethoxy-2-(4-methoxy-phenyl)-chromen-4-one oxime 

Relevant articles and documents

COMPOUNDS, COMPOSITION AND USES THEREOF FOR TREATING CANCER

The present invention relates to the fields of medicine and cancer treatment. The invention more specifically relates to new compounds which are typically for use as a medicament. In particular, the invention relates to the use of these new compounds for increasing the presentation, typically the production and presentation, of Pioneer Translation Products (PTPs)-derived antigens by cancer cells in a subject, and inducing or stimulating an immune response in the subject. The present disclosure also relates to uses of such compounds, in particular to prepare a pharmaceutical composition and/or to allow or improve the efficiency of a cancer therapy in a subject in need thereof. The invention also discloses methods for preventing or treating cancer, cancer metastasis and/or cancer recurrence in a subject. The present invention in addition provides kits suitable for preparing a composition according to the present invention and/or for implementing the herein described methods.

A new strategy for the synthesis of biflavonoids via arylboronic acids

Amentoflavone derivatives were prepared by catalytic coupling of 8-flavone-boronic acids with iodoflavones. 3-Arylflavones, as biflavonoid synthon, are accessible by the method.

Biflavones from Leaves of Cupressus gracilis and Cupressus macrocarpa

-